Chronic cough, defined as a cough persisting for more than eight weeks, is a common yet challenging condition encountered in primary care. It significantly impacts the quality of life and necessitates a comprehensive understanding for effective management.
The pathophysiology of chronic cough is multifactorial, often associated with conditions such as gastroesophageal reflux disease (GERD), asthma, and upper airway cough syndrome (UACS). However, in some cases, the cause remains unidentifiable, leading to the term 'idiopathic chronic cough'.
A thorough history and physical examination form the cornerstone of diagnosis. Investigations such as chest X-ray, spirometry, and bronchoscopy may be warranted based on clinical suspicion. Empirical treatment trials for common causes like GERD and UACS may also aid in identifying the underlying etiology.
Treatment is primarily aimed at addressing the underlying cause. For instance, proton pump inhibitors for GERD, inhaled corticosteroids for asthma, and antihistamines for UACS. Moreover, cough suppressants and behavioural therapy play a crucial role in managing idiopathic chronic cough.
Recent advancements have introduced novel therapies targeting neuronal pathways involved in cough reflex. P2X3 antagonists, such as gefapixant, have shown promising results in reducing cough frequency, thus offering potential new avenues for treatment.
Chronic cough is a complex condition requiring a comprehensive approach for diagnosis and management. Understanding the underlying mechanisms, adopting a systematic diagnostic approach, and being aware of the latest advancements in treatment strategies are crucial for healthcare professionals in providing optimal patient care. Ongoing research into the pathophysiology of chronic cough and the development of novel treatments is likely to further improve patient outcomes in the future.
1.
Expert Q&A: A Drug Holiday for Metastatic Prostate Cancer?
2.
Ivonescimab Tops Pembrolizumab in PD-L1-Positive, Advanced NSCLC
3.
Weight loss trial reports success for breast cancer patients at one year mark
4.
Tissue-Free ctDNA Strongly Prognostic of Recurrence in TNBC
5.
Adding SBRT to systemic therapy could boost outcomes for some locally advanced hepatocellular carcinoma patients
1.
Navigating the Challenges of Vaso-Occlusive Crisis: A Guide for Patients and Caregivers
2.
Single-Cell Lineage Tracing in Hematology: Decoding the Cellular Blueprint of Blood Disorders
3.
AI-Powered Strategies for Precision and Improved Outcomes in Esophageal Cancer, a Global Health Crisis
4.
Unlocking the Power of Neutrophils: Harnessing Their Disease-Fighting Potential
5.
Epigenetic Subtyping of Complex Hematologic Disorders
1.
International Conference on Oncology, Cardiology and Critical Care Policy
2.
International Conference on Innovations in Critical Care for Oncology and Cardiology
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Cancer Nursing and Hematology Support
1.
Updates on the First Line Management of ALK+ NSCLC
2.
L858R Mutation- An Overview of Retrospective Cohort Study in Advanced NSCLC Patients
3.
Navigating the Complexities of Ph Negative ALL - Part V
4.
Newer Immunotherapies for Myeloma- A Comprehensive Overview- Part II
5.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation